Skip to content

Continuous Versus Intermittent Bolus Infusion of Paravertebral Blocks for Thoracic Surgery

A Comparison Between Continuous Versus Intermittent Bolus Infusion of Paravertebral Blocks for Thoracic Surgery: A Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03480984
Enrollment
50
Registered
2018-03-29
Start date
2018-02-05
Completion date
2020-01-31
Last updated
2020-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thoracic Diseases

Brief summary

The researchers are trying to determine pain medication consumption in the first 24 hours after surgery in patients given the standard continuous infusion of local anesthetic versus patients given the same total dose via programmed intermittent dosing. Both groups will receive the option of patient controlled pain medication as well as the same dose of pre-programmed pain medication. The only difference is the rate of administration: continuous vs. hourly intervals.

Interventions

6 mL 0.2% ropivacaine hourly, starting on arrival to PACU, given via an hourly programmed bolus

6 mL 0.2% ropivacaine hourly, starting on arrival to PACU, given via continuous infusion

Sponsors

Mayo Clinic
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
SINGLE (Investigator)

Masking description

Investigators will not have direct access to settings on the pump

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Documentation of planned thoracic surgery for which a paravertebral catheter is indicated based on surgeon request as well as appropriateness of location of surgical site. * Ability for subject to comply with the requirements of the study.

Exclusion criteria

* Pregnancy. * Coagulopathy at time of evaluation or surgery. * Infection at the site of needle insertion. * Allergy to local anesthetic. * Patient refusal. * Chronic opioid use

Design outcomes

Primary

MeasureTime frameDescription
Opioid consumption 24 hours postoperativelyfirst 24 hours postoperativelymorphine equivalents of opioids in mg will be obtained from medical record

Secondary

MeasureTime frameDescription
Opioid consumption 48 hours postoperativelyfirst 48 hours postoperativelymorphine equivalents of opioids in mg will be obtained from medical record

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026